SL Science Holding SLBT
NASDAQ SLBT
$1.27 +0.07 (+5.83%)
At close: Nov 2, 2026 · 4:00 PM EST

SL Science Holding (SLBT) Cash from Financing Activities (2026)

Updated

SL Science Holding (SLBT) posted Cash from Financing Activities of $43.06 million for Q2 2026.

Analysis

SL Science Holding (SLBT) Cash from Financing Activities (2026) Analysis & Trends

For FY2025, SL Science Holding's Cash from Financing Activities came in at -$879,137.

  • In prior years, SL Science Holding's Cash from Financing Activities was $3.07 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,263.50 Bn 1,237.12 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 655.05 Bn 574.91 Bn 17.30 Bn -8.53 Bn
3 AbbVie 512.00 Bn 485.11 Bn 12.70 Bn -5.05 Bn
4 Merck 368.57 Bn 368.57 Bn - -
5 Novartis Ag 313.61 Bn 286.85 Bn - -
6 Astrazeneca 290.22 Bn 263.91 Bn 12.86 Bn -3.89 Bn
7 Amgen 252.64 Bn 208.04 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 212.62 Bn 212.62 Bn - -1.53 Bn
9 Pfizer 175.96 Bn 122.60 Bn 10.94 Bn -3.66 Bn
10 SL Science Holding 2.68 Bn 2.67 Bn - 43.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 43.06 Mn
Mar 31, 2026 -33.90 Mn
API Access

SL Science Holding Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SLBT&period=max&api_key=YOUR_API_KEY